| Bruce M Hensel, MD | |
|
1350 W Covina Blvd, San Dimas, CA 91773-3245 | |
| (909) 599-6811 | |
| (818) 587-2493 |
| Full Name | Bruce M Hensel |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 1350 W Covina Blvd, San Dimas, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700824083 | NPI | - | NPPES |
| 00G420900 | Medicaid | CA | |
| 00G420900 | Other | CA | BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | G42090 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Bruce M Hensel, MD Po Box 4419, Woodland Hills, CA 91365-4419 Ph: (800) 358-9787 | Bruce M Hensel, MD 1350 W Covina Blvd, San Dimas, CA 91773-3245 Ph: (909) 599-6811 |
News Archive
High-deductible health insurance plans coupled with health savings accounts (tax-advantaged funds for covering medical costs), are becoming the plan of choice for Connecticut's small businesses newly offering insurance to employees, Hartford Business reports.
A new study shows that higher doses of radiation do not improve survival for many patients with prostate cancer, compared with the standard radiation treatment.
The Society of Thoracic Surgeons has released new clinical practice guidelines for treating cancer of the esophagus and gastroesophageal junction (area where the esophagus meets the stomach).
Inflammatory bowel diseases (IBDs), including Crohn disease and ulcerative colitis, are hard to completely cure. Globally, IBDs affect more than 4 million people, today. However, Professor Soichi Tanabe (Graduate School of Biosphere Science, Hiroshima University) and his collaborators have demonstrated that 10-hydroxy-cis-12-octadecenoic acid (HYA), a gut microbial metabolite of linoleic acid, has a suppressive effect on intestinal inflammation.
TxCell SA, a biotechnology company developing novel and innovative, cost-effective personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that it has enrolled the first patient in its phase IIb clinical trial of its lead product Ovasave in refractory Crohn's disease.
› Verified 4 days ago
James V Pagano, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1350 W Covina Blvd, San Dimas, CA 91773 Phone: 909-599-6811 Fax: 818-587-2493 | |
Nadine Konia, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1350 W Covina Blvd, San Dimas, CA 91773 Phone: 909-599-6811 Fax: 818-587-2493 | |
Dr. Corbett G Peek, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1350 W Covina Blvd, San Dimas, CA 91773 Phone: 909-599-6811 | |
Ray Zhao, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1350 W Covina Blvd, San Dimas, CA 91773 Phone: 626-872-3457 | |
Glenn I Kane, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1350 W Covina Blvd, San Dimas, CA 91773 Phone: 909-599-6811 Fax: 818-587-2493 | |
Brenda N Hayakawa, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1350 W Covina Blvd, San Dimas, CA 91773 Phone: 909-599-6811 Fax: 818-587-2493 |